Interleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study
Rosalinda Posadas-Sánchez , Ángel Rene López-Uribe , José Manuel Fragoso , Gilberto Vargas-Alarcón
{"title":"Interleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study","authors":"Rosalinda Posadas-Sánchez , Ángel Rene López-Uribe , José Manuel Fragoso , Gilberto Vargas-Alarcón","doi":"10.1016/j.yexmp.2024.104886","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and aims</h3><p>Interleukin-6 (IL-6) is an acute-phase protein that plays an important role in the inflammatory response, vascular inflammation, and atherosclerosis process. The study aimed to establish whether <em>IL-6</em> gene polymorphisms and IL-6 concentrations are associated with premature coronary artery disease (pCAD) and cardiovascular risk factors.</p></div><div><h3>Methods</h3><p>The IL-6 concentrations and the rs2069827, rs1800796, and rs1800795 IL-6 polymorphisms were determined in 1150 pCAD patients and 1083 healthy controls (coronary artery calcium equal to zero determined by tomography).</p></div><div><h3>Results</h3><p>The <em>IL-6</em> polymorphisms studied were not associated with pCAD, but they were associated with cardiovascular risk factors in patients and controls. In controls, under the dominant model, the rs1800795 <em>C</em> allele and the rs2069827 <em>T</em> allele were associated with a low risk of central obesity (OR = 0.401, <em>p</em> = 0.017 and OR = 0.577, <em>p</em> = 0.031, respectively), hypoalphalipoproteinemia (OR = 0.581, <em>p</em> = 0.027 and OR = 0.700, <em>p</em> = 0.014, respectively) and hypertriglyceridemia (OR = 0.575, <em>p</em> = 0.030 and OR = 0.728, <em>p</em> = 0.033, respectively). In pCAD, the rs1800795 <em>C</em> allele was associated with an increased risk of hypoalphalipoproteinemia (OR = 1.370, <em>p</em><sub>additive</sub> = 0.025) and increased C-reactive protein (CRP) concentrations (OR = 1.491, <em>p</em><sub>additive</sub> = 0.007). pCAD patients had significantly higher serum IL-6 concentrations compared to controls (<em>p</em> = 0.002). In the total population, individuals carrying the rs1800795 <em>GC + CC</em> genotypes had higher levels of IL-6 than carriers of the <em>GG</em> genotype (<em>p</em> = 0.025). In control individuals carrying the <em>C</em> allele (<em>CG + CC</em>), an inverse correlation was observed between IL-6 and HDL-cholesterol levels (<em>p</em> = 0.003).</p></div><div><h3>Conclusions</h3><p>In summary, the <em>IL-6</em> polymorphisms were not associated with pCAD, however, they were associated with cardiovascular risk factors in pCAD patients and healthy controls. Individuals carrying the rs1800795 <em>GC + CC</em> genotypes had higher levels of IL-6 than carriers of the <em>GG</em> genotype.</p></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"136 ","pages":"Article 104886"},"PeriodicalIF":2.8000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0014480024000054/pdfft?md5=cca370e10e0d5fbb3a699bf21646d904&pid=1-s2.0-S0014480024000054-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and molecular pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014480024000054","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims
Interleukin-6 (IL-6) is an acute-phase protein that plays an important role in the inflammatory response, vascular inflammation, and atherosclerosis process. The study aimed to establish whether IL-6 gene polymorphisms and IL-6 concentrations are associated with premature coronary artery disease (pCAD) and cardiovascular risk factors.
Methods
The IL-6 concentrations and the rs2069827, rs1800796, and rs1800795 IL-6 polymorphisms were determined in 1150 pCAD patients and 1083 healthy controls (coronary artery calcium equal to zero determined by tomography).
Results
The IL-6 polymorphisms studied were not associated with pCAD, but they were associated with cardiovascular risk factors in patients and controls. In controls, under the dominant model, the rs1800795 C allele and the rs2069827 T allele were associated with a low risk of central obesity (OR = 0.401, p = 0.017 and OR = 0.577, p = 0.031, respectively), hypoalphalipoproteinemia (OR = 0.581, p = 0.027 and OR = 0.700, p = 0.014, respectively) and hypertriglyceridemia (OR = 0.575, p = 0.030 and OR = 0.728, p = 0.033, respectively). In pCAD, the rs1800795 C allele was associated with an increased risk of hypoalphalipoproteinemia (OR = 1.370, padditive = 0.025) and increased C-reactive protein (CRP) concentrations (OR = 1.491, padditive = 0.007). pCAD patients had significantly higher serum IL-6 concentrations compared to controls (p = 0.002). In the total population, individuals carrying the rs1800795 GC + CC genotypes had higher levels of IL-6 than carriers of the GG genotype (p = 0.025). In control individuals carrying the C allele (CG + CC), an inverse correlation was observed between IL-6 and HDL-cholesterol levels (p = 0.003).
Conclusions
In summary, the IL-6 polymorphisms were not associated with pCAD, however, they were associated with cardiovascular risk factors in pCAD patients and healthy controls. Individuals carrying the rs1800795 GC + CC genotypes had higher levels of IL-6 than carriers of the GG genotype.
期刊介绍:
Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature''s most jealously guarded secrets on the pathologic basis of disease.
Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.